サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420190

北米のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ、用途、供給源、タイプ別

North America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日: | 発行: The Insight Partners | ページ情報: 英文 90 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米のオルガノイド市場の2030年までの予測-地域別分析：臓器タイプ、用途、供給源、タイプ別
出版日: 2023年11月29日
発行: The Insight Partners
ページ情報: 英文 90 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のオルガノイド市場は、2022年の11億2,501万米ドルから2030年には53億5,972万米ドルに成長すると予測されています。2022年から2030年までのCAGRは21.5%と推定されます。

個別化医療の普及が北米のオルガノイド市場を後押し

個別化医療は精密医療とも呼ばれ、予測される反応や病気のリスクに基づいて個々の患者に合わせた処置や薬剤を実践する医療モデルです。個別化医療連合（PMC）が発表した調査によると、2005年にFDAが承認した新規分子実体のうち個別化医療が占める割合はわずか5％であったのに対し、2016年には25％を超えています。さらに、全化合物の42％、パイプラインにあるがん領域の化合物の73％が個別化医療になる可能性があります。さらに、バイオ医薬品企業は、個別化医薬品への研究開発投資を過去5年間でほぼ倍増させており、今後5年間で33％増加すると見られています。バイオ医薬品の研究者も、今後5年間で個別化医薬品の開発が69％増加すると予測しています。PMCの最新レポート（2021年発表）によると、米国では、市場に出回る個別化医薬品の数は、2016年の132から2020年には286に増加しています。このデータは、PMCが2008年以降の個別化医療の数を追跡して共有したものです。

オルガノイドの導入による個別化薬物療法の実現は、患者ケアを改善するエキサイティングな機会を提供します。また、薬剤師は精密医療について積極的に教育し、認知度を高めることで、個別化医薬品の需要拡大に不可欠な役割を果たしています。最近の調査では、50％以上の消費者がカスタマイズされた製品やサービスの購入に関心を持っていることが明らかになった。この需要は、医薬品をより安全で効果的なものにするため、よりカスタマイズされた治療法を開発するよう製薬研究を説得しています。

個別化がん医療は、腫瘍のゲノム的特徴に従って、患者ごとに効果的な治療戦略を調整するアプローチです。前臨床におけるゲノムの薬物反応予測の機能的側面を確認するために、個別化腫瘍モデリングの調査に対する需要が高まっています。遺伝子と薬剤の関連治療、新しい治療法の同定、患者の転帰の予測などの観点から、個別化がん医療における腫瘍オルガノイドの応用が、数多くの研究で強調されています。

個別化がん治療は、それぞれの患者に特異的な治療を適用するものです。元の腫瘍と類似した特徴を持つ個別化腫瘍モデルを用いることで、患者の薬物反応を正確に予測できる可能性があります。腫瘍オルガノイドモデルには、既存のモデルよりも元の腫瘍の分子・細胞組成を保存できるなど、いくつかの利点があります。これらの利点は、特に前臨床薬物スクリーニングや選択した治療レジメンに対する患者の反応予測など、個別化がん治療における腫瘍オルガノイドの大きな可能性を浮き彫りにしています。

北米のオルガノイド市場概要

北米のオルガノイド市場は米国、カナダ、メキシコに区分されます。2022年には、米国が北米のオルガノイド市場で最大のシェアを占めました。慢性疾患やウイルス性疾患に罹患する患者の増加、研究開発活動の活発化、オルガノイドモデルの商品化、幹細胞研究における画期的な進歩が、オルガノイド市場を推進する主な要因です。また、オルガノイド開発のための資金援助や助成金の増加も市場拡大を後押ししています。

北米のオルガノイド市場の収益と2030年までの予測（金額）

北米のオルガノイド市場のセグメンテーション

北米のオルガノイド市場は、臓器の種類、用途、供給源、タイプ、国に区分されます。

臓器タイプに基づき、北米のオルガノイド市場は腸、肝臓、胃、膵臓、肺、脳、腎臓、その他に区分されます。2022年の北米のオルガノイド市場では、腸セグメントが最大のシェアを占めています。

用途別では、北米のオルガノイド市場は発生生物学的疾患、感染症病理学、再生医療、薬物毒性・有効性試験、創薬・個別化医療、その他に区分されます。2022年の北米のオルガノイド市場では、発生生物学疾患分野が最大のシェアを占めています。

供給源に基づき、北米のオルガノイド市場は多能性幹細胞と臓器特異的成体幹細胞に二分されます。2022年の北米のオルガノイド市場では、多能性幹細胞分野が大きなシェアを占めています。

北米のオルガノイド市場は、タイプ別に機器、消耗品、サービスに区分されます。消耗品セグメントは2022年に北米のオルガノイド市場で最大のシェアを占めました。

国別では、北米のオルガノイド市場は米国、カナダ、メキシコに区分されます。2022年の北米のオルガノイド市場は米国が支配的でした。

STEMCELL Technologies Inc、Cellsce Ltd、Organoid Therapeutics、3Dnamics Inc、Thermo Fisher Scientific Inc、Merck KGaA、InSpheroは、北米のオルガノイド市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 北米主要洞察
  • 北米市場の魅力

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のオルガノイド市場情勢

  • 概観
  • 北米PEST分析

第5章 北米のオルガノイド市場- 主要産業力学

  • 主な市場促進要因
    • 腫瘍モデリングとバイオバンクの需要増加
    • 個別化医薬品の採用拡大
    • 動物実験モデルの代替品開発への注目の高まり
  • 主な市場抑制要因
    • 既存のワークフローへのオルガノイドの組み込みに関する問題
    • 熟練した専門家の不足
  • 主な市場機会
    • 創薬活動の重視
  • 今後の動向
    • オルガノイドとOrgan-On-A-Chipの組み合わせ
  • 影響分析

第6章 オルガノイド市場：北米市場分析

  • 北米のオルガノイド市場の収益、2022年～2030年

第7章 北米のオルガノイド市場-収益と2030年までの予測：臓器タイプ別

  • 北米のオルガノイド市場-2022年および2030年収益シェア（%）臓器タイプ別
  • 胃
  • 腸
  • 肝臓
  • 膵臓
  • 肺
  • 脳
  • 腎臓
  • その他

第8章 北米のオルガノイド市場-収益と2030年までの予測：用途別

  • 北米のオルガノイド市場-2022年および2030年収益シェア（%）用途別
  • 発生生物学
  • 感染症病態学
  • 再生医療
  • 薬物毒性および有効性試験
  • 創薬および個別化医療
  • その他

第9章 北米のオルガノイド市場-収益と2030年までの予測：供給源別

  • 北米のオルガノイド市場-2022年および2030年収益シェア（%）供給源別
  • 多能性幹細胞
  • 臓器特異的成体幹細胞

第10章 北米のオルガノイド市場-収益と2030年までの予測：タイプ別

  • 北米のオルガノイド市場-2022年および2030年収益シェア（%）タイプ別
  • 機器
  • 消耗品
  • サービス

第11章 北米のオルガノイド市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第12章 COVID-19前後の影響

  • COVID-19前後の影響

第13章 北米のオルガノイド市場業界情勢

  • 市場参入企業の成長戦略（%）
  • 有機開発
  • 無機開発

第14章 北米のオルガノイド市場：主要企業プロファイル

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第15章 付録

図表

List Of Tables

  • Table 1. North America Organoids Market Segmentation
  • Table 2. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. US Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, North America Organoids Market

List Of Figures

  • Figure 1. North America Organoids Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Organoids Market, 2022 (US$Mn)
  • Figure 30. North America Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 31. US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Pre & Post Covid-19 Impact
  • Figure 35. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00018845

The North America organoid market is expected to grow from US$ 1,125.01 million in 2022 to US$ 5,359.72 million by 2030. It is estimated to grow at a CAGR of 21.5% from 2022 to 2030.

Growing Adoption of Personalized Drugs Fuel North America Organoids Market

Personalized medicine, also known as precision medicine, is a medical model that practices procedures or drugs tailored to the individual patient based on the projected response or risk of disease. According to a study published by Personalized Medicine Coalition (PMC), personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005, whereas they accounted for more than 25% in 2016. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, which is likely to increase by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines over the coming five years. According to the latest report by the PMC (published in 2021), in the US, the number of personalized medicines in the market has risen from 132 in 2016 to 286 in 2020. The data was shared by tracking the numbers of personalized medicine since 2008 by the PMC.

The implementation of organoids to create personalized drug therapies provides exciting opportunities for improving patient care. In addition, pharmacists play an essential role in increasing the demand for personalized medicines as they proactively educate and create awareness about precision medicine. Recent research has highlighted that more than 50% of consumers are interested in purchasing customized products or services. This demand has persuaded pharmaceutical research to develop more tailored treatments to make medicines safer and more effective.

Personalized cancer medicine is an approach to tailoring effective therapeutic strategies for each patient according to a tumor's genomic characterization. There is an increasing demand for research in personalized tumor modeling to confirm the functional aspects of genomic drug response predictions in the preclinical setting. Numerous studies have highlighted the application of tumor organoids in personalized cancer medicine in terms of gene-drug association treatment, identification of new therapies, and prediction of patient outcomes.

Personalized cancer therapy applies specific treatments to each patient. Using personalized tumor models with similar characteristics to the original tumors may result in accurate predictions of drug responses in patients. Tumor organoid models have several advantages, such as conserving the molecular and cellular composition of the original tumor over pre-existing models. These advantages highlight the tremendous potential of tumor organoids in personalized cancer therapy, particularly in preclinical drug screening and predicting patient responses to selected treatment regimens.

North America Organoids Market Overview

The North America organoids market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America organoids market. Rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development, commercialization of organoid models, and breakthroughs in stem cell research are the key factors propelling the market for organoids. Also, the growing funding and grants for organoid development are favoring market expansion.

North America Organoid Market Revenue and Forecast to 2030 (US$ Million)

North America Organoids Market Segmentation

The North America organoid market is segmented into organ type, application, source, type, and country.

Based on organ type, the North America organoid market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the North America organoid market in 2022.

Based on application, the North America organoid market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the North America organoid market in 2022.

Based on source, the North America organoid market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the North America organoid market in 2022.

Based on type, the North America organoid market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.

Based on country, the North America organoid market is segmented int o the US, Canada, and Mexico. The US dominated the North America organoid market in 2022.

STEMCELL Technologies Inc, Cellesce Ltd, Organoid Therapeutics, 3Dnamics Inc, Thermo Fisher Scientific Inc, Merck KGaA, and InSphero are some of the leading companies operating in the North America organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America organoids market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 North America Key Insights
  • 2.2 North America Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Organoids Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - North America Market Analysis

  • 6.1 North America Organoids Market Revenue (US$ Mn), 2022 - 2030

7. North America Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 North America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 North America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 North America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: North America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Organoids Market - Country Analysis

  • 11.1 North America: Overview
    • 11.1.1 North America Organoids Market, by Country
      • 11.1.1.1 US
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 US Organoids Market, by Organ Type
        • 11.1.1.1.4 US Organoids Market, by Application
        • 11.1.1.1.5 US Organoids Market, by Source
        • 11.1.1.1.6 US Organoids Market, by Type
      • 11.1.1.2 Canada
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 Canada Organoids Market, by Organ Type
        • 11.1.1.2.4 Canada Organoids Market, by Application
        • 11.1.1.2.5 Canada Organoids Market, by Source
        • 11.1.1.2.6 Canada Organoids Market, by Type
      • 11.1.1.3 Mexico
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 Mexico Organoids Market, by Organ Type
        • 11.1.1.3.4 Mexico Organoids Market, by Application
        • 11.1.1.3.5 Mexico Organoids Market, by Source
        • 11.1.1.3.6 Mexico Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. North America Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. North America Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Organoid Therapeutics
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
    • 14.4.3Dnamics Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Thermo Fisher Scientific Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Merck KGaA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 InSphero
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms